NIH-funded research R01 grant

Understanding how an extra chromosome affects organ development in Down Syndrome

Official title: A heterochronic model for birth defects in Down Syndrome

Funded at University of Chicago · NIH-10658360 · Data updated 2026-11-12

This study is looking at how an extra chromosome 21 can cause heart and brain problems in babies with Down Syndrome, hoping to understand why these issues happen so that we can learn more about their development.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2023
Award (this year)$5,035,031
NIH project number1R01HD111938-01
Project IDNIH-10658360 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Down Syndrome, particularly those with congenital heart defects or intellectual disabilities.

Less likely to help

Patients without Down Syndrome or those who do not exhibit congenital defects may not benefit from this research.

What this research studies

This research investigates how an additional copy of chromosome 21 leads to specific birth defects associated with Down Syndrome, particularly focusing on the development of the heart and brain. By studying the molecular mechanisms involved in organ development, the research aims to uncover the reasons behind structural abnormalities that are present at birth. The approach includes examining the role of Hedgehog signaling in regulating the growth and differentiation of organ-specific progenitor cells. This could provide insights into the timing and processes that lead to congenital defects in individuals with Down Syndrome.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential interventions for congenital defects in individuals with Down Syndrome.

How similar studies have gone: Previous research has shown promising results in understanding congenital defects through similar molecular approaches, indicating potential for success in this area.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Moskowitz, Ivan Paul — University of Chicago
  • Study coordinator: Moskowitz, Ivan Paul

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.